HDAC9 and cancer: Previous studies have shown that HDAC inhibitors can inhibit the activity of HDACs, restore histone acetylation, induce apoptosis of cancer cells, and inhibit their proliferation (Bolden et al., 2006; Liu and Liou, 2023).